In Vitro Susceptibility of 30 Strains of Chlamydia trachomatis to Rosamicin |
| |
| Authors: | Thomas F. Smith and Harriet E. Washton |
| |
| Affiliation: | 1Department of Laboratory Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, 55901;2Schering Corporation, Bloomfield, New Jersey 07003 |
| |
| Abstract: | A total of 13 of 30 clinical isolates of Chlamydia trachomatis were susceptible in vitro to 0.01 μg of rosamicin per ml. Only two of these strains were susceptible to tetracycline or erythromycin at this level. The results suggest that rosamicin may be useful for the treatment of chlamydial urethritis. |
| |
| Keywords: | |
|
|
